Semaglutide Impurity Peptides
105 listed variantsSequence-related, stereochemical, degradation-related and lipidation-associated Semaglutide research peptides.
Custom Semaglutide, Retatrutide and Tirzepatide impurity peptides for analytical method development, HPLC and LC-MS comparison, stability investigations, forced-degradation research and related-substance studies.
Peptide-related impurities may differ from the intended parent peptide by stereochemistry, amino-acid sequence, oxidation state, side-chain structure, linker composition, acylation pattern or terminal processing. These variants may arise during synthesis and purification or may be generated during handling, storage and stress studies.
LifeTein provides individually synthesized impurity peptides for research programs that require defined, sequence-specific materials. Projects can be reviewed according to the requested sequence, purity, quantity, salt form, analytical package and intended research use.
Sequence-related, stereochemical, degradation-related and lipidation-associated Semaglutide research peptides.
Custom impurity peptides related to the long, modified and lipidated Retatrutide sequence.
Tirzepatide stereochemical, sequence-related, linker-related and degradation-related research peptides.
Stereochemical variants in which an intended L-residue is replaced by the corresponding D-residue or another stereoisomer.
Peptides lacking one or more residues or containing incomplete N-terminal or C-terminal sequence regions.
Defined Asp-related isomers, including β-aspartyl or isoaspartyl-type sequence variants where applicable.
Oxidized or otherwise transformed peptides prepared for comparison in analytical and stability-related research.
Sequence variants containing a specified amino-acid replacement at a defined position.
Peptides with altered spacer, linker, conjugation or fatty-acid components relative to the parent sequence.
Peptides with specified changes in N-terminal or C-terminal processing, protection or sequence length.
Project-specific sequences proposed by a customer for feasibility review and custom synthesis.
| Application | How a Defined Impurity Peptide May Be Used |
|---|---|
| HPLC or UPLC method development | Evaluate chromatographic separation and retention behavior. |
| LC-MS comparison | Support mass, retention-time and fragmentation comparison. |
| Related-substance investigations | Examine a proposed sequence-related or chemically modified variant. |
| Forced-degradation research | Compare stress-study peaks with defined candidate materials. |
| Stability-method research | Support development or evaluation of stability-indicating procedures. |
| Process-development research | Investigate process-related peptide variants during synthesis or purification studies. |
LifeTein is a New Jersey-based CRO founded in 2008. The company supports custom peptide projects ranging from short peptides to long and modified sequences. Current LifeTein service information lists peptide lengths from 2 to 170 amino acids, multiple purity options, broad modification support, preparative purification, analytical HPLC and mass-spectrometry confirmation.
Technical review for long, hydrophobic, repetitive and heavily modified sequences.
Selectable quantity, purity, salt form and project-specific analytical requirements.
Analytical HPLC, mass-spectrometry confirmation and supporting documentation according to the quoted package.
Provide the catalog number, sequence or proposed structural variant.
LifeTein evaluates sequence complexity, scale, purity and analytical needs.
The peptide is synthesized and purified according to the accepted quotation.
Agreed HPLC, MS and documentation are prepared for delivery.
No general claim of compendial or certified-reference-standard status is made. They are custom research peptides unless a separate, project-specific qualification package is expressly agreed.
Yes. Submit the proposed sequence or structural change for feasibility review, pricing and lead-time evaluation.
Yes. Available purity, scale and analytical options depend on the sequence and project requirements.
Analytical HPLC and mass-spectrometry confirmation can be included according to the quotation.
Salt-form or counterion requirements can be reviewed during quotation.
Provide the catalog number or sequence, quantity, purity, salt form, analytical requirements and intended research application.
Defined peptide-related materials may support analytical procedure development and comparison studies. The appropriate use, qualification, acceptance criteria and regulatory suitability remain the responsibility of the customer and depend on the intended application.
Send the catalog number or sequence together with the desired quantity, purity, salt form and analytical package. Unlisted candidate impurities can also be reviewed.
Request a QuoteFor research use only. Not for human, veterinary, diagnostic, therapeutic or clinical use.